| Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study Y Otsuka, C Kiyohara, Y Kashiwado, T Sawabe, S Nagano, Y Kimoto, ... PLoS One 13 (4), e0196368, 2018 | 56 | 2018 |
| Shared epitope positivity is related to efficacy of abatacept in rheumatoid arthritis K Oryoji, K Yoshida, Y Kashiwado, K Tanaka, S Mizuki, H Tsukamoto, ... Annals of the Rheumatic Diseases 77 (8), 1234-1236, 2018 | 35 | 2018 |
| Antibody response to SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases in Japan: Interim analysis of a multicentre cohort study Y Kashiwado, Y Kimoto, T Sawabe, K Irino, S Nakano, J Hiura, Q Wang, ... Modern Rheumatology 33 (2), 367-372, 2023 | 14 | 2023 |
| Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis Y Arinobu, Y Kashiwado, K Miyawaki, M Ayano, Y Kimoto, H Mitoma, ... Medicine 100 (13), e25406, 2021 | 9 | 2021 |
| Intestinal Behçet’s disease with pyoderma gangrenosum successfully treated with the combination therapy of adalimumab and glucocorticoids Y Kashiwado, A Uchino, T Ota, S Nagano Modern Rheumatology 28 (5), 901-905, 2018 | 9 | 2018 |
| IgG4-related disease presenting as a paraneoplastic syndrome: report of two cases and literature review M Akahoshi, Y Arinobu, Y Kashiwado, A Omoto, M Ayano, H Mitoma, ... Modern Rheumatology Case Reports 5 (2), 371-376, 2021 | 4 | 2021 |
| Immunosuppressive therapy and humoral response to third mRNA COVID-19 vaccination with a six-month interval in rheumatic disease patients Y Kashiwado, Y Kimoto, S Ohshima, T Sawabe, K Irino, S Nakano, J Hiura, ... Rheumatology 63 (3), 725-733, 2024 | 3 | 2024 |
| Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus … C Saiki, Y Kashiwado, T Yokoyama, M Ayano, K Imabayashi, S Kawano, ... Modern Rheumatology Case Reports 6 (2), 183-188, 2022 | 3 | 2022 |
| Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan Y Kashiwado, Y Kimoto, K Oku, M Yamamoto, S Ohshima, S Ito, ... Modern Rheumatology 34 (3), 576-583, 2024 | 1 | 2024 |
| Clinical course of patients with rheumatoid arthritis who continue or discontinue biologic therapy after hospitalization for infection: a retrospective observational study Y Kashiwado, C Kiyohara, Y Kimoto, S Nagano, T Sawabe, K Oryoji, ... Arthritis Research & Therapy 24 (1), 131, 2022 | 1 | 2022 |
| AB0291 Association between Pentosidine, an Advanced Glycation End-Product, and Disease Activity in Patients with Untreated Rheumatoid Arthritis. A Preliminary Report S Mizuki, Y Kashiwado, K Yoshida, K Oryoji, K Kamada, E Yokota Annals of the Rheumatic Diseases 73 (Suppl 2), 900-900, 2014 | | 2014 |
